THxID™-BRAF 410697

GUDID 03573026354909

The THxID™ BRAF kit is an IVD real time PCR device intended for the qualitative detection of the BRAF V600E and V600K mutations in human melanoma tissue

BIOMERIEUX SA

BRAF V600 gene mutation IVD, kit, nucleic acid technique (NAT) BRAF V600 gene mutation IVD, kit, nucleic acid technique (NAT) BRAF V600 gene mutation IVD, kit, nucleic acid technique (NAT) BRAF V600 gene mutation IVD, kit, nucleic acid technique (NAT) BRAF V600 gene mutation IVD, kit, nucleic acid technique (NAT) BRAF V600 gene mutation IVD, kit, nucleic acid technique (NAT) BRAF V600 gene mutation IVD, kit, nucleic acid technique (NAT) BRAF V600 gene mutation IVD, kit, nucleic acid technique (NAT) BRAF V600 gene mutation IVD, kit, nucleic acid technique (NAT) BRAF V600 gene mutation IVD, kit, nucleic acid technique (NAT) BRAF V600 gene mutation IVD, kit, nucleic acid technique (NAT) BRAF V600 gene mutation IVD, kit, nucleic acid technique (NAT) BRAF V600 gene mutation IVD, kit, nucleic acid technique (NAT) BRAF V600 gene mutation IVD, kit, nucleic acid technique (NAT) BRAF V600 gene mutation IVD, kit, nucleic acid technique (NAT) BRAF V600 gene mutation IVD, kit, nucleic acid technique (NAT)

• Primary Device ID: 03573026354909
• NIH Device Record Key: 8b000a1f-4104-4eaf-a589-289edd1b4fa4
• Commercial Distribution Status: In Commercial Distribution
• Brand Name: THxID™-BRAF
• Version Model Number: 410697
• Catalog Number: 410697
• Company DUNS: 276816717
• Company Name: BIOMERIEUX SA
• Device Count: 1
• DM Exempt: false
• Pre-market Exempt: false
• MRI Safety Status: Labeling does not contain MRI Safety Information
• Human Cell/Tissue Product: false
• Device Kit: true
• Device Combination Product: false
• Single Use: false
• Lot Batch: true
• Serial Number: false
• Manufacturing Date: false
• Expiration Date: true
• Donation Id Number: false
• Contains Natural Rubber Latex: false
• Labeled No Natural Rubber Latex: false
• RX Perscription: true
• OTC Over-The-Counter: false

Operating and Storage Conditions

• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing Agency	Device ID
GS1	03573026354909 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

• Premarket Approval: P120014

FDA Product Code

• OWD: Somatic Gene Mutation Detection System

Sterilization

• Steralize Prior To Use: false
• Device Is Sterile: false

Device Entry Metadata

• Public Version Status: Update
• Device Record Status: Published
• Public Version Number: 7
• Public Version Date: 2022-01-26
• Device Publish Date: 2014-09-23

Devices Manufactured by BIOMERIEUX SA

• 03573026256685 - ETEST® Gentamicin (GM): 2024-04-15 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1
• 03573026376604 - ETEST® Amoxicillin (AC): 2024-04-15 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1
• 03573026377731 - ETEST® Flucytosine (FC): 2024-04-15 Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions
• 03573026560690 - ETEST® Meropenem/Vaborbactam (MEV): 2024-04-15 ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative an
• 03573026475352 - ETEST® Telavancin (TLA): 2024-04-12 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1
• 03573026252526 - ETEST® Cefepime (PM): 2024-04-08 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1
• 03573026253219 - Etest® TIC/CLAV-CON2: 2024-04-08 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1
• 03573026617851 - VITEK®MS: 2024-03-18 VITEK MS ready to use reagent for calibration and fine tuning of the VITEK MS instrument